Importantly, in pancreatic cancer specifically, LY6E was suggested to be a marker for cancer cells with stem cell properties and was used in addition to the stem cell markers TACSTD1 and CD44 to establish a sorting technique to obtain clonal colony-forming pancreatic cancer stem cells [47]. Here, CD44 is linked to familial pancreatic carcinoma.